Fingerprint
Dive into the research topics of 'No benefit of continuing vs stopping 5-aminosalicylates in patients with ulcerative colitis escalated to anti-metabolite therapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
No benefit of continuing vs stopping 5-aminosalicylates in patients with ulcerative colitis escalated to anti-metabolite therapy
Siddharth Singh*, Jihoon Kim, Wenhong Zhu, Parambir S. Dulai, William J. Sandborn, Vipul Jairath
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
10
Scopus
citations